Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson
International Journal of Molecular Sciences · 13.04.2023 · 24 (8) · 7221
DOI: 10.3390/ijms24087221 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.04.2023. Verfasst von Annalisa Tassone und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, 00143 Rome, Italy. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Parkinson Disease, Huntington Disease. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 262 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health “Ricerca Finalizzata”.
Abstract (Originalsprache)
Strong evidence suggests a correlation between degeneration and mitochondrial deficiency. Typical cases of degeneration can be observed in physiological phenomena (i.e., ageing) as well as in neurological neurodegenerative diseases and cancer. All these pathologies have the dyshomeostasis of mitochondrial bioenergy as a common denominator. Neurodegenerative diseases show bioenergetic imbalances in their pathogenesis or progression. Huntington’s chorea and Parkinson’s disease are both neurodegenerative diseases, but while Huntington’s disease is genetic and progressive with early manifestation and severe penetrance, Parkinson’s disease is a pathology with multifactorial aspects. Indeed, there are different types of Parkinson/Parkinsonism. Many forms are early-onset diseases linked to gene mutations, while others could be idiopathic, appear in young adults, or be post-injury senescence conditions. Although Huntington’s is defined as a hyperkinetic disorder, Parkinson’s is a hypokinetic disorder. However, they both share a lot of similarities, such as neuronal excitability, the loss of striatal function, psychiatric comorbidity, etc. In this review, we will describe the start and development of both diseases in relation to mitochondrial dysfunction. These dysfunctions act on energy metabolism and reduce the vitality of neurons in many different brain areas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, 00143 Rome, Italy.
- Saint Camillus International University of Health and Medical Sciences, 00131 Rome, Italy.
- Unit of Neurology, Department of Systems Medicine, Tor Vergata University of Rome, 00133 Rome, Italy.
ORCID-Profile: Paola Bonsi, Giuseppina Martella
Förderung
- Italian Ministry of Health “Ricerca Finalizzata”
Zitieren
APA
Tassone, A., Meringolo, M., Ponterio, G., Bonsi, P., Schirinzi, T., & Martella, G. (2023). Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson. International Journal of Molecular Sciences, 24(8), 7221. https://doi.org/10.3390/ijms24087221
Vancouver
Tassone A, Meringolo M, Ponterio G, Bonsi P, Schirinzi T, Martella G. Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson. International Journal of Molecular Sciences. 2023;24(8):7221. doi:10.3390/ijms24087221
BibTeX
@article{Tassone2023,
author = {Tassone, Annalisa and Meringolo, Maria and Ponterio, Giulia and Bonsi, Paola and Schirinzi, Tommaso and Martella, Giuseppina},
title = {Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {8},
pages = {7221},
doi = {10.3390/ijms24087221}
}
EUVIMED